U.S. Energy Services Stock News

OTCPK:SWDR
OTCPK:SWDRREITs

Starwood Real Estate Income Trust (OTCPK:SWDR) FFO Loss Rekindles Dividend Sustainability Debate

Starwood Real Estate Income Trust (OTCPK:SWDR) has posted its FY 2025 numbers with fourth quarter revenue of US$402.8 million, a basic EPS loss of US$0.39, and funds from operations of US$4.4 million in the red, setting the tone for a year where trailing twelve month revenue reached about US$1.6 billion alongside a net loss of US$691.6 million. Over recent quarters, revenue has moved in a tight band between US$389.7 million and US$420.2 million while EPS has remained in loss territory. As a...
NasdaqCM:EXAS
NasdaqCM:EXASBiotechs

The Bull Case For Exact Sciences (EXAS) Could Change Following Walgreens’ Nationwide Cologuard Pharmacy Rollout

In March 2026, Walgreens announced a nationwide initiative with Exact Sciences and Workflow Services that lets eligible, average-risk customers request the FDA-approved, at-home Cologuard colorectal cancer screening test through its pharmacies, aiming to close care gaps with pharmacist-led services integrated into store workflows. At the same time, Exact Sciences highlighted new data on its Oncodetect molecular residual disease test and Cancerguard multi-cancer early detection assay at the...
NasdaqGS:TSHA
NasdaqGS:TSHABiotechs

Taysha Gene Therapies Advances Rett Program As Valuation Draws Investor Focus

Taysha Gene Therapies (NasdaqGS:TSHA) received FDA Breakthrough Therapy designation for TSHA-102 in Rett syndrome. The company reported a 100% patient response rate in pivotal Phase I/II data for TSHA-102. Regulators aligned with Taysha on pivotal trial designs for its lead Rett syndrome program. Taysha added a key commercial hire as it prepares for potential TSHA-102 commercialization. Taysha Gene Therapies, trading at $4.4 per share, has been drawing attention as its 1 year return stands...
NasdaqGS:AMBA
NasdaqGS:AMBASemiconductor

Ambarella Accelerates Edge AI Shift While Shares Trade Below Valuation Estimates

Ambarella (NasdaqGS:AMBA) used a recent industry conference to outline a faster push into Edge AI products. The company highlighted a major shift in its revenue mix, new sales efforts aimed at smaller customers, and progress on a semi custom chip. Management also disclosed work on an upcoming two nanometer chip, signaling a move to more advanced manufacturing nodes. Ambarella, trading at about $54.02, has seen a mixed share price record, with a 3.3% gain over the past week but a 28.1%...
NYSE:YRD
NYSE:YRDConsumer Finance

Yiren Digital (YRD) Valuation Check After Earnings Slump And Dividend Suspension

Yiren Digital (YRD) is back in focus after Q4 2025 results showed revenue of CN¥957.63 million, a net loss of CN¥882.16 million, and a temporary suspension of its cash dividend for the second half of 2025. See our latest analysis for Yiren Digital. The earnings miss and dividend suspension appear to have weighed heavily on sentiment, with a 7 day share price return of 44.19% and a 1 year total shareholder return of 69.72%. The 3 year total shareholder return remains slightly positive, which...
NasdaqGS:HTFL
NasdaqGS:HTFLHealthcare Services

HeartFlow’s AI Data And New Tools Reframe Coronary Disease Investment Story

HeartFlow (NasdaqGS:HTFL) reported landmark real world data at ACC 2026 showing its AI Plaque Analysis as a leading independent predictor for cardiovascular risk stratification. The Plaque Analysis data is linked with improved patient outcomes and substantial cost savings in coronary artery disease management. The company launched the large scale NAVIGATE PCI Registry to study its AI driven PCI Navigator tool ahead of commercial release. HeartFlow’s AI platform is now backed by FDA cleared...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) Q3 2026 EPS Growth Challenges Cautious Earnings Narratives

FedEx Q3 2026 Earnings Snapshot FedEx (FDX) has put up another solid set of quarterly numbers, with Q3 2026 revenue at US$24.0 billion and basic EPS of US$4.47, giving investors a clear look at how the business is performing through the current fiscal year. The company has seen revenue move from US$21.2 billion in Q3 2025 to US$24.0 billion in Q3 2026, while quarterly basic EPS shifted from US$3.78 to US$4.47 over the same period. The trailing twelve month net profit margin now sits at 4.9%...
NYSE:HXL
NYSE:HXLAerospace & Defense

Hexcel’s Recycled Composites And Falcon 10X Role Shape Valuation Story

Hexcel is collaborating through the ECCA initiative with James Cropper to develop aerospace grade composites using recycled carbon fibre, supporting circularity and lower waste in advanced materials. The company is also a key materials supplier for Dassault Aviation's Falcon 10X program, which has reached an important aircraft rollout milestone. These developments highlight Hexcel's role in both sustainable material solutions and next generation business jets across the aerospace...
NYSE:JKS
NYSE:JKSSemiconductor

JinkoSolar’s Nextpower Deal Deepens U.S. Roots As Valuation Gap Persists

JinkoSolar Holding (NYSE:JKS) has entered a multi year supply agreement with Nextpower for U.S. manufactured steel module frames. The partnership centers on steel frames and deeper localization of JinkoSolar's U.S. solar module supply chain. The agreement supports JinkoSolar's efforts to source key components domestically and align with U.S. solar infrastructure priorities. For investors tracking NYSE:JKS, this move comes with the stock at around $23.4 and a mixed performance profile...
NasdaqGS:ARCB
NasdaqGS:ARCBTransportation

ArcBest Climate Vote Puts Board Priorities And Valuation In Focus

ArcBest's board is urging shareholders to vote against a climate related proposal ahead of the upcoming annual meeting. The proposal calls for the company to set greenhouse gas emission reduction targets. The board's stance highlights tension between management and some shareholders over environmental priorities and disclosure. ArcBest (NasdaqGS:ARCB) enters this vote with a current share price of $87.58 and a mixed recent return profile. The stock is up 3.2% over the past week and 13.5%...
NYSE:UAMY
NYSE:UAMYMetals and Mining

United States Antimony (UAMY) Revenue Surge Tests Bullish Growth Narratives Against Ongoing Losses

United States Antimony (UAMY) has just reported its FY 2025 numbers, with Q4 revenue of about US$13.0 million and a basic EPS loss of roughly US$0.002. Trailing 12 month figures show revenue at around US$39.3 million and a basic EPS loss of about US$0.035. Over the past six reported quarters, revenue has moved from roughly US$2.6 million in Q3 2024 to US$13.0 million in Q4 2025, with quarterly EPS ranging between a profit of about US$0.0048 and a loss of roughly US$0.039. This sets up a...
NasdaqGM:FLY
NasdaqGM:FLYAerospace & Defense

Firefly Aerospace (FLY) Narrows Quarterly Losses Challenging Skeptics On Profitability Path

Firefly Aerospace (FLY) just closed FY 2025 with fourth quarter revenue of US$57.7 million and a basic EPS loss of US$0.26, alongside trailing twelve month revenue of US$159.9 million and a TTM EPS loss of US$4.83, versus very large revenue growth of 163% over the past year. Over recent quarters, the company has seen revenue move from US$9.0 million in Q4 2024 to US$57.7 million in Q4 2025 while quarterly basic EPS losses shifted from US$7.86 to US$0.26. This leaves investors weighing robust...
NYSE:JAN
NYSE:JANHealth Care REITs

Janus Living (JAN) Valuation Check As Investors Reassess This Senior Housing REIT

Janus Living stock: why this senior housing REIT is on investor radars Janus Living (JAN) has attracted fresh attention after a recent 1 day return of 0.18% and a last close of $23.60, prompting investors to reassess this senior housing focused U.S. REIT. See our latest analysis for Janus Living. The recent 1 day share price return of 18% and year to date share price return of 18% at a current level of $23.60 suggest momentum has been building in a short period. This may hint at shifting...
NasdaqCM:CLSK
NasdaqCM:CLSKSoftware

Is It Time To Reassess CleanSpark (CLSK) After Big Multi Year Share Price Gains?

If you are wondering whether CleanSpark's current share price lines up with its underlying worth, this breakdown will help you connect the stock chart to valuation numbers. CleanSpark closed at US$9.40, with returns of 1.4% over the last 30 days, an 18.6% decline year to date, gains of 26.3% over 1 year, and a very large 3 year return of 249.4%, set against a 55.3% decline over 5 years. Recent coverage has focused on CleanSpark as part of broader commentary on software and tech related...
NYSE:DRI
NYSE:DRIHospitality

Darden Restaurants (DRI) Margin Slippage Tests Bullish Profit Expansion Narrative In Q3 2026

Darden Restaurants (DRI) just turned in its Q3 2026 scorecard, reporting revenue of US$3.3b and basic EPS of US$2.70. This helps investors weigh the latest quarter against its recent track record. Over the past few periods, revenue has moved from US$3.2b in Q3 2025 to US$3.3b in Q3 2026, while basic EPS went from US$2.76 to US$2.70, giving a clear sense of where the top and bottom lines currently sit. With net profit margin now at 8.7% versus 9.0% a year earlier, the story for this quarter...
NYSE:ANDG
NYSE:ANDGProfessional Services

Is It Time To Reassess Andersen Group (ANDG) After Its Recent Share Price Surge?

If you are wondering whether Andersen Group at US$27.90 is offering fair value or an opportunity, the next sections will walk through what the current price really reflects. The stock has posted returns of 22.2% over the last 7 days, 24.6% over the last 30 days and 14.4% year to date, which has likely caught the eye of investors watching for changing risk and return profiles. Recent coverage has focused on Andersen Group's share price moves and how investors are reassessing the company, with...
NasdaqGM:EH
NasdaqGM:EHAerospace & Defense

Evaluating EHang Holdings (EH) After Its Return To Quarterly Profit And Higher Sales

EHang’s earnings jump puts quarterly profit in focus EHang Holdings (NasdaqGM:EH) just released its fourth quarter and full year 2025 results, reporting quarterly sales of CN¥243.78 million and net income of CN¥10.49 million. This follows a net loss in the prior year period. See our latest analysis for EHang Holdings. The earnings surprise has arrived against a weak recent share price backdrop, with a 1 day share price return of 8.46% decline, a 30 day share price return of 19.04% decline,...
NasdaqGS:BTSG
NasdaqGS:BTSGHealthcare

BrightSpring Refocuses On Home Care As De Leveraging And M&A Advance

BrightSpring Health Services (NasdaqGS:BTSG) is reallocating capital toward acquisitions and organic growth in its core home and clinical services. The company is accelerating de-leveraging efforts to increase financial flexibility. BrightSpring plans to divest its community-living operations, with the transaction expected to close soon. BrightSpring operates in home and clinical care, an area that sits at the intersection of aging demographics, pressure on institutional care settings, and...
NYSE:CBZ
NYSE:CBZProfessional Services

Is CBIZ (CBZ) Now A Value Opportunity After A 63% One Year Share Price Fall

If you are wondering whether CBIZ's share price now reflects its true worth, the starting point is understanding how that price lines up against different measures of value. The stock recently closed at US$27.02, with returns of 3.4% over the last week, a 9.5% decline over the past month, and longer term returns of a 46.8% decline year to date and a 63.0% decline over the past year. These moves sit against a backdrop where investors have been reassessing many professional services names,...
NYSE:XPEV
NYSE:XPEVAuto

XPeng (NYSE:XPEV) Turns Quarterly EPS Positive Challenging Longstanding Profitability Concerns

XPeng (NYSE:XPEV) closed FY 2025 with fourth quarter revenue of C¥22.3b and basic EPS of C¥0.40, while trailing twelve month figures show total revenue of C¥76.7b and a basic EPS loss of C¥1.20, keeping the story firmly focused on scale over the bottom line. The company’s quarterly revenue moved from C¥10.1b in Q3 2024 to C¥22.3b in Q4 2025, with basic EPS shifting from a C¥1.91 loss to C¥0.40, so the latest results sit against a backdrop of expanding sales and still thin margins that...
NasdaqGS:TYRA
NasdaqGS:TYRABiotechs

Boone Capital Backs Tyra Biosciences As FGFR3 Trials Shape Outlook

Boone Capital Management has disclosed a significant new position in Tyra Biosciences. The investment comes as Tyra Biosciences advances multiple clinical trials centered on FGFR3 biology. The move highlights fresh institutional interest in NasdaqGS:TYRA at a current share price of $37.15. For readers tracking Tyra Biosciences, the company now sits at a share price of $37.15 with substantial recent share price momentum, including a 26.4% return over the past 30 days and 38.7% year to date...
NYSE:PL
NYSE:PLProfessional Services

Planet Labs (PL) Q4 Loss Deepens To US$0.48 EPS Challenging Bullish Growth Narratives

Planet Labs PBC (PL) has just closed out FY 2026 with fourth quarter revenue of US$86.8 million and a basic EPS loss of US$0.48. Trailing twelve month revenue stood at US$307.7 million and EPS at a loss of US$0.80. Over recent periods, the company has seen quarterly revenue move from US$61.6 million in FY 2025 Q4 to US$66.3 million in FY 2026 Q1, US$73.4 million in Q2, US$81.3 million in Q3 and US$86.8 million in Q4. This has come alongside a sequence of widening quarterly EPS losses from...
NasdaqGM:IDN
NasdaqGM:IDNSoftware

Intellicheck (IDN) Q4 EPS Breakthrough Tests High Growth Narrative Against 87.9x P/E

Intellicheck (IDN) has rounded out FY 2025 with fourth quarter revenue of about US$6.6 million and basic EPS of roughly US$0.08, alongside trailing twelve month revenue of US$22.7 million and EPS of about US$0.07 that reflect a move into positive net income of around US$1.3 million over the year. The company has seen quarterly revenue progress from US$4.9 million in Q1 2025 to US$6.6 million in Q4 2025, with EPS shifting from a small loss of roughly US$0.02 per share early in the year to a...
NasdaqGS:LIN
NasdaqGS:LINChemicals

Linde’s Oshkosh Plant And What It Means For Midwest Growth

Linde plans to build a new industrial gases facility in Oshkosh, Wisconsin. The project is intended to expand supply capacity for industrial customers across the Midwest. The development marks a further investment in regional infrastructure for NasdaqGS:LIN. Linde, trading on NasdaqGS:LIN, is moving ahead with construction of a new industrial gases facility in Oshkosh, Wisconsin, adding to its US footprint. The company’s shares most recently closed at $488.15, with a return of 13.8% year to...